Article
Defining Outcomes for Clinical Trials of Leber Congenital Amaurosis Caused by GUCY2D Mutations.
American journal of ophthalmology - 1 May 2017
Jacobson Samuel G, Cideciyan Artur V, Sumaroka Alexander, Roman Alejandro J, Charng Jason, Lu Monica, Choudhury Shreyasi, Schwartz Sharon B, Heon Elise, Fishman Gerald A, Boye Shannon E
Abstract excerpt
PURPOSE: To determine outcome measures for a clinical trial of Leber congenital amaurosis (LCA) associated with mutations in the GUCY2D gene. DESIGN: Retrospective observational case series. METHODS: Twenty-eight patients with GUCY2D-LCA (aged 2-59 years) were studied clinically and with chromatic full-field sensitivity testing (FST), optical coherence tomography (OCT), pupillometry, and the NEI Visual Function...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
